Stage III endometrial cancer refers to stage III endometrial cancer according to FIGO staging, and it is impossible to generalize how many years a patient can live, but according to Oncology, it suggests that the five-year survival rate of stage III endometrial cancer is about 50%.
Endometrial cancer is a relatively common malignant tumor disease of reproductive system for women nowadays, and stage III endometrial cancer means that the tumor cells have already spread locally or regionally.
For patients with stage III endometrial cancer, the prognosis obtained by an individual is related to various factors such as pathological stage, physical condition, age and so on. According to Oncology, the five-year survival rate for stage III endometrial cancer achieved with standardized treatment is about 50 percent, with some patients with specific types of pathology being even lower.
Regardless of the stage of development of an individual’s disease, he or she should receive standardized treatment to improve the quality of life and survival of the individual and prolong the survival period. Women should be aware of the need for regular gynecological examinations and seek medical attention for any physical abnormalities.